Cagrilintide: What the Evidence Actually Shows The pivotal standalone human dataset for cagrilintide is a multicentre, randomised, double-blind, placebo- and active-controlled, dose-finding Phase 2 trial in people with overweight or obesity
They will consider making necessary changes in the dosing schedule or prescribing other medications to help manage the temporary side effects
We review the medical history, baseline labs, weight-related conditions, medication risks, side effects, insurance barriers, muscle preservation, and the long-term maintenance plan
Not for Use in Diagnostic Procedures
Need help with injection technique, side effects, or support
Temperatures near the cooling element can drop below freezing and damage the medication without you realizing it